Cell Therapy Account Management North Carolina South Carolina bei Iovance Biotherapeutics

The ideal candidate will live in North Carolina or South Carolina.

Overview

Amtagvi™ is the best-in-class cell therapy treatment for advanced melanoma. The Cell Therapy Account Management Associate (CTAM) will be responsible for contributing to pipeline growth of Amtagvi demand by developing a referral network between community practices and academic centers; enable early patient identification and streamline referral pathways; and collaborate with internal teams to ensure scientific and operational excellence in cell therapy account management.

To succeed in this role, you will use prior experience in a similar role within the oncology rare disease space. The ability to influence others, perform referral and education activities, building awareness and relationships. You are expected to understand account management and strategy planning. Additional competencies include knowledge of immunotherapy and solid tumor cancer, as well as the ability to launch, drive demand, pull through, and sustain the growth of Amtagvi™.

Essential Functions and Responsibilities:

• Drive Amtagvi^TM demand and appropriate pull-through at targeted ATCs and serve as a liaison between community oncology practices and internal stakeholders to align initiatives with business and medical objectives.
• Collaborates closely with Iovance iPOD at authorized treatment centers offering commercially available Amtagvi^TM. Responsible for developing and onboarding a new TIL service line at target ATCs.
• Educate site personnel on clinical and product information for Amtagvi^TM.
• Provide knowledge around Iovance products and processes to all service line customer stakeholders.
• Collaborate with ATC Operations, to ensure Iovance Cell Therapy logistics, processes, and operations.
• Provide customer service w
  
  Please mention the word **ENJOY** and tag ROTQuMTU2LjEzMS40Nw== when applying to show you read the job post completely (#ROTQuMTU2LjEzMS40Nw==). This is a beta feature to avoid spam applicants. Companies can search these words to find applicants that read this and see they're human.